Healthcare
Wednesday, August 31, 2016
BRIEF-Aspen Pharmacare to buy exclusive rights to commercialise AstraZeneca's anaesthetics portfolio
* Had signed an agreement with AstraZeneca whereby AGI will
acquire exclusive rights to commercialise astrazeneca's global
(excluding USA) anaesthetics portfolio
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment